Stock Details
FRE.DE is Fresenius SE & Co. KGaA's stock. Stock exchange XETRA (Currency EUR). Average price in 50 days is 26.97โ‚ฌ. Average daily volumn in 3 months 1.23M. Market cap 15.67B



Stock symbol : FRE.DE. Exchange : XETRA. Currency : EUR
Lastest price : 27.82โ‚ฌ. Total volume : 1.33M. Market state PREPRE
Click reload if you want to check the lastest price on market!!!

Fresenius SE & Co. KGaA (FRE.DE)
Last Price
27.82โ‚ฌ
Change
0.42
Volume
1.33M

Previous Close27.40
Open27.54
Day Range27.49-28.03
Bid27.86 x N/A
Ask27.87 x N/A
Volume1.33M
Average Volume1.23M
Market Cap15.67B
Beta1.08
52 Week Range19.69-38.10
Trailing P/E9.66
Foward P/E9.00
Dividend (Yield %)3.36%
Ex-Dividend Date2022-05-16



Financial Details


According to Fresenius SE & Co. KGaA's financial reports the company's revenue in 2021 were 37.52B an increase( +2.78%) over the years 2020 revenue that were of 36.28B. In 2021 the company's total earnings were 1.82B while total earnings in 2020 were 1.71B(0%).


Loading ...



Organization

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi s... egment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hรถhe, Germany.

Market Cap:
15.67B
Revenue:
37.52B
Total Assets:
71.96B
Total Cash:
2.76B


News about "Fresenius SE & Co. KGaA"

are-investors-undervaluing-fresenius-se-co-kgaa-etrfre-by-36-image

Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 36%?

Source from : YAHOO!Finance - 1 days ago

Today we will run through one way of estimating the intrinsic value of Fresenius SE & Co. KGaA by estimating the company's future cash flows and discounting them to their present ...See details»


Fresenius SE & Co KGaA

Source from : Newsweek - 1 month ago

Fresenius SE & Co. KGaA is a European health care company based in Bad Homburg, Germany. The Fresenius Group provides products and services for dialysis, hospitals as well as inpatient and ...See details»


Fresenius SE KGaA (ETR:FRE) shareholders have endured a 57% loss from investing in the stock five years ago

Source from : Yahoo - 1 month ago

While it may not be enough for some shareholders, we think it is good to see the Fresenius SE & Co. KGaA (ETR:FRE) share price up 20% in a single quarter. But that can't change the reality that ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : Wall Street Journal - 6 days ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»


Fresenius Medical Care AG & Co. KGaA (FMS) Sits On Its Hands At $18.74

Source from : stocksregister - 11 days ago

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) concluded the trading at $18.74 on Friday, January 27 with a rise of 3.77% from its closing price on previous day. Taking a look at stock we notice that ...See details»


Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 46%?

Source from : Yahoo - 28 days ago

How far off is Fresenius Medical Care AG & Co. KGaA (ETR:FME) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting ...See details»


Fresenius Medical Care KGaA (ETR:FME) Will Be Hoping To Turn Its Returns On Capital Around

Source from : Yahoo News - 1 month ago

Having said that, from a first glance at Fresenius Medical Care KGaA (ETR:FME) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look. If you haven't worked with ...See details»


Fresenius SE

Source from : Fortune - 3 years ago

ยฉ 2022 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»


Fresenius Medical Care KGAA ST (FMEd)

Source from : Investing - 11 month ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»


Fresenius Medical Care AG Common Stock (FMS)

Source from : Nasdaq - 8 years ago

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...See details»


Fresenius Medical Care Stock (NYSE:FMS), Quotes and News Summary

Source from : Benzinga.com - 2 years ago

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. In addition to providing ...See details»


Fresenius SE & Co. KGaA ADR

Source from : Wall Street Journal - 2 years ago

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»


Fresenius Medical Care AG & Co. KGaA ADR

Source from : Morningstar%2c Inc. - 6 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»


Fresenius SE KGaA (ETR:FRE) shareholders have endured a 57% loss from investing in the stock five years ago

Source from : Yahoo Finance - 1 month ago

While it may not be enough for some shareholders, we think it is good to see the Fresenius SE & Co. KGaA (ETR:FRE) share price up 20% in a single quarter. But that can't change the reality that over ...See details»